FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

Revance Therapeutics, Inc.: capex

One fact, its scope and the complete path back to the official record.

Period: 2016-01-01 – 2016-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/4138ee71-399c-4e49-aa27-ac1e73092a7d

Reported value

$690.000k{"amount": 690000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
capex
Period
2016-01-01 – 2016-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001479290-16-000039 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:23.327228+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/capex/2016-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies